At a glance
Year of investment: 2021
Revenues 2021: 44m EUR
Number of FTEs 2021: 364
Chief Innovation Officer and Founder : Dr. Tobias Schäfer
Board: to be announced
Year of investment: 2021
Revenues 2021: 44m EUR
Number of FTEs 2021: 364
Chief Innovation Officer and Founder : Dr. Tobias Schäfer
Board: to be announced
Trill Impact facilitated a strategic merger of Meona and i-SOLUTIONS in an effort to establish a market-leading software player to drive digitalization of healthcare providers and to improve treatment quality, patient safety and access to care.
Founded in 2008 by the current management team, including two doctors from the well-regarded Freiburg University Clinic, Meona is today a market-leading clinical software provider for medical documentation, workflow and patient management. The company focuses on improving the efficiency in medical digital infrastructure for its customer base of mid- to large-sized hospitals in continental Europe.
With products designed to improve patient safety and quality of care, Meona offers a comprehensive clinical software suite that covers the entire patient journey. Aimed at supporting doctors and nurses at their key “pressure points” during a work shift, the product modules support emergency room workflows, medication management and nursing documentation, as well as vital and ambulatory parameters tracking and quality control.
Meona has grown both organically and via acquisitions in recent years and has developed strong relationships to the large teaching (university) hospitals in Germany, with the result that the majority of these hospitals have implemented the Meona software suite. The company is headquartered in Freiburg where it employs around 100 people. While Germany is currently the main market, Meona also has a presence in Belgium, Norway, Austria, Switzerland and the Netherlands.
Originating from the late 1980s, i-SOLUTIONS is a specialized German company offering workflow and patient management software for small- to mid-sized hospitals, digital imaging facilities and laboratories with tailormade requirements.
i-SOLUTIONS is headquartered in Mannheim and runs five additional office locations in Germany, employing around 210 people. Complementing Meona’s product range, i-SOLUTIONS offers a more administration-focused software suite to healthcare institutions. The company thereby contributes the efficiency of care across hospitals and adjacent healthcare institutions like laboratories and imaging centers through the following:
This proprietary merger situation was created by Trill Impact to combine Meona’s clinical software with i-SOLUTIONS’ administration-focused software suite and seeks to take advantage of an attractive market driven by mega-trends.
Key impact and investment attractions include:
By combining the two companies, Trill Impact enables Meona and i-SOLUTIONS to offer their customers an unparalleled, one-stop-shop solution for clinical and administrative medical software.
Dr. Tobias Schäfer, medical doctor and CEO: “With Trill Impact, we have found an owner who shares our vision and entrepreneurial spirit. Looking ahead, we want to combine our strength in innovation with the experience and product range of i-SOLUTIONS. This will help make us the market-leading software provider in the healthcare sector. We are confident that our customers will benefit enormously from this partnership."
The purpose of the combined Meona and i-SOLUTIONS software solution is to improve the quality and efficacy of healthcare, and to address the issue of patient safety in hospitals.
Meona and i-SOLUTIONS are a driving force for digitization of health care providers, providing the infrastructure and clinical applications for improved health outcomes.
Quality and efficacy of healthcare are at risk with a high number of avoidable adverse events and avoidable deaths occurring in German hospitals every year.
German hospitals lag in digital health, contributing to the lack of continuity of care and coordinated care for patients.
SDG #3.4 Reduce premature mortality from diseases through prevention and treatment
SDG #9.1 Develop quality, reliable and resilient infrastructure, to support human well-being